 | Up a level |
Reid, DM; Devogelaer, JP; Saag, K; Roux, C; Lau, CS; Reginster, JY; Papanastasiou, P; Ferreira, A; Hartl, F; Fashola, T; Mesenbrink, P; Sambrook, PN; Perrelet, Romain; HORIZON, investigators (2009). Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet, 373(9671), pp. 1253-1263. London: Elsevier 10.1016/S0140-6736(09)60250-6
Cornuz, Jacques; Krieg, Marc-Antoine; Sandini, Lorenzo; Ruffieux, Christiane; Van Melle, Guy; Burckhardt, Peter; Büche, D; Dambacher, M; Hartl, F; Häuselmann, H; Lippuner, K; Neff, M; Pancaldi, P; Rizzoli, R; Tanzi, F; Theiler, R; Tyndall, A; Wimpfheimer, C; SEMOF, research group (2003). Factors associated with the use of hormone replacement therapy among older women. Age and ageing, 32(6), pp. 675-8. Oxford: Oxford University Press 10.1093/ageing/afg099b
Krieg, M A; Cornuz, J; Ruffieux, C; Sandini, L; Büche, D; Dambacher, M A; Hartl, F; Häuselmann, H J; Kraenzlin, M; Lippuner, K; Neff, M; Pancaldi, P; Rizzoli, R; Tanzi, F; Theiler, R; Tyndall, A; Wimpfheimer, K; Burckhardt, P (2003). Comparison of three bone ultrasounds for the discrimination of subjects with and without osteoporotic fractures among 7562 elderly women. Journal of bone and mineral research, 18(7), pp. 1261-6. Hoboken, N.J.: Wiley-Blackwell 10.1359/jbmr.2003.18.7.1261
Krieg, M A; Cornuz, J; Hartl, F; Kraenzlin, M; Tyndall, A; Häuselmann, H J; Lippuner, K; Rizzoli, R; Büche, D; Theiler, R; Dambacher, M A; Neff, M; Pancaldi, P; Tanzi, F; Wimpfheimer, K; Burckhardt, P (2002). Quality controls for two heel bone ultrasounds used in the Swiss Evaluation of the Methods of Measurement of Osteoporotic Fracture Risk Study. Journal of clinical densitometry, 5(4), pp. 335-41. New York, N.Y.: Elsevier 10.1385/JCD:5:4:335
